A transition from the BPharm to the PharmD degree in five selected countries
| Autor: | Payom Wongpoowarak, Teeraporn Supapaan, Claire Anderson, Summana Moolasarn, Bee Yean Low |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
lcsh:RS1-441
Pharmaceutical Science Pharmacy Review mesh:Japan 030226 pharmacology & pharmacy 0302 clinical medicine Japan Health care Pakistan mesh:Schools Program Development mesh:Pakistan mesh:Students Scope (project management) Thailand mesh:Program Development Pharmacy practice Clinical Competence Curriculum Clinical competence mesh:United States mesh:Pharmacy Educational quality mesh:Curriculum mesh:Clinical Competence Students Pharmacy Education lcsh:Pharmacy and materia medica 03 medical and health sciences Pharmacy Students Political science Republic of Korea Accreditation Medical education business.industry Schools Pharmacy lcsh:RM1-950 Education Pharmacy mesh:Education United States mesh:Pharmaceutical Services lcsh:Therapeutics. Pharmacology mesh:Republic of Korea Pharmaceutical Services mesh:Thailand Pharmacy Schools business |
| Zdroj: | Pharmacy Practice Pharmacy Practice (Granada), Volume: 17, Issue: 3, Article number: 1611, Published: 25 NOV 2019 Pharmacy Practice, Vol 17, Iss 3, p 1611 (2019) Pharmacy Practice (Granada) v.17 n.3 2019 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname |
| ISSN: | 1885-642X |
| Popis: | This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, South Korea, Pakistan and Thailand. The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme that are designed to meet the needs of their countries. Each country created a different process to handle the transition to an all-PharmD programme, but mostly had the process of school accreditation mandated by the regulatory bodies. The main barrier to the transition in most of the countries was the issue of educational quality. A set of indicators is needed to measure and monitor the impact/outcome of the PharmD degree. Each country has different needs due to the different contexts of health care systems and the scope of pharmacy practice. In order to increase their chances of benefiting from the new programme, academic leaders should critically assess their countries’ needs before deciding to adopt a PharmD programme. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|